← FDA Drug Approvals (Drugs@FDA)
LORATADINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2023-07-28
Drug application
- FDA Application #
ANDA211718- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LORATADINE
- Generic name
- LORATADINE
- Active ingredients
- LORATADINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Over-the-counter
- Sponsor
- HETERO LABS LTD V
- Manufacturer
- Camber Consumer Care Inc
- First approval
- 2023-07-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown